338 related articles for article (PubMed ID: 26108901)
1. Treatment of latent tuberculosis infection induces changes in multifunctional Mycobacterium tuberculosis-specific CD4+ T cells.
Sauzullo I; Mengoni F; Mascia C; Rossi R; Lichtner M; Vullo V; Mastroianni CM
Med Microbiol Immunol; 2016 Feb; 205(1):37-45. PubMed ID: 26108901
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional Analysis of CD4+ T-Cell Response as Immune-Based Model for Tuberculosis Detection.
Lichtner M; Mascia C; Sauzullo I; Mengoni F; Vita S; Marocco R; Belvisi V; Russo G; Vullo V; Mastroianni CM
J Immunol Res; 2015; 2015():217287. PubMed ID: 26339657
[TBL] [Abstract][Full Text] [Related]
3. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
Pathakumari B; Devasundaram S; Maddineni P; Raja A
Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
[TBL] [Abstract][Full Text] [Related]
4. Impact of antiretroviral and tuberculosis therapies on CD4
Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
[TBL] [Abstract][Full Text] [Related]
5. Multi-functional flow cytometry analysis of CD4+ T cells as an immune biomarker for latent tuberculosis status in patients treated with tumour necrosis factor (TNF) antagonists.
Sauzullo I; Scrivo R; Mengoni F; Ermocida A; Coppola M; Valesini G; Vullo V; Mastroianni CM
Clin Exp Immunol; 2014 Jun; 176(3):410-7. PubMed ID: 24528189
[TBL] [Abstract][Full Text] [Related]
6. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection.
Caccamo N; Guggino G; Joosten SA; Gelsomino G; Di Carlo P; Titone L; Galati D; Bocchino M; Matarese A; Salerno A; Sanduzzi A; Franken WP; Ottenhoff TH; Dieli F
Eur J Immunol; 2010 Aug; 40(8):2211-20. PubMed ID: 20540114
[TBL] [Abstract][Full Text] [Related]
8. HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses.
Amelio P; Portevin D; Hella J; Reither K; Kamwela L; Lweno O; Tumbo A; Geoffrey L; Ohmiti K; Ding S; Pantaleo G; Daubenberger C; Perreau M
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541853
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.
Gao Y; Zhang S; Ou Q; Shen L; Wang S; Wu J; Weng X; Chen ZW; Zhang W; Shao L
Hum Immunol; 2015 Nov; 76(11):801-7. PubMed ID: 26429305
[TBL] [Abstract][Full Text] [Related]
10. Cell-Mediated Immune Responses to
Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
Front Immunol; 2020; 11():103. PubMed ID: 32117257
[TBL] [Abstract][Full Text] [Related]
11. Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection.
Chiacchio T; Delogu G; Vanini V; Cuzzi G; De Maio F; Pinnetti C; Sampaolesi A; Antinori A; Goletti D
PLoS One; 2017; 12(8):e0183846. PubMed ID: 28837654
[TBL] [Abstract][Full Text] [Related]
12. CD137 is a Useful Marker for Identifying CD4
Yan ZH; Zheng XF; Yi L; Wang J; Wang XJ; Wei PJ; Jia HY; Zhou LJ; Zhao YL; Zhang HT
Scand J Immunol; 2017 May; 85(5):372-380. PubMed ID: 28218958
[TBL] [Abstract][Full Text] [Related]
13. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
[TBL] [Abstract][Full Text] [Related]
14. Study of CD27 and CCR4 Markers on Specific CD4
Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
Front Immunol; 2018; 9():3094. PubMed ID: 30687314
[TBL] [Abstract][Full Text] [Related]
15. Activation Phenotype of
Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
Front Immunol; 2021; 12():721013. PubMed ID: 34512645
[TBL] [Abstract][Full Text] [Related]
16. Co-infection with Mycobacterium tuberculosis impairs HIV-Specific CD8+ and CD4+ T cell functionality.
Chetty S; Govender P; Zupkosky J; Pillay M; Ghebremichael M; Moosa MY; Ndung'u T; Porichis F; Kasprowicz VO
PLoS One; 2015; 10(3):e0118654. PubMed ID: 25781898
[TBL] [Abstract][Full Text] [Related]
17. First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus.
Petruccioli E; Chiacchio T; Pepponi I; Vanini V; Urso R; Cuzzi G; Barcellini L; Cirillo DM; Palmieri F; Ippolito G; Goletti D
J Infect; 2016 Dec; 73(6):588-597. PubMed ID: 27717779
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte subset analysis in QuantiFERON-TB Gold Plus and T-Spot.TB for latent tuberculosis infection in rheumatoid arthritis.
Igari H; Ishikawa S; Nakazawa T; Oya Y; Futami H; Tsuyuzaki M; Suzuki K; Matsumura R
J Infect Chemother; 2018 Feb; 24(2):110-116. PubMed ID: 29054459
[TBL] [Abstract][Full Text] [Related]
19. Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.
Commandeur S; Lin MY; van Meijgaarden KE; Friggen AH; Franken KL; Drijfhout JW; Korsvold GE; Oftung F; Geluk A; Ottenhoff TH
Eur J Immunol; 2011 Oct; 41(10):2925-36. PubMed ID: 21728172
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
